These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 24528518)
41. The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. Kamya MR; Byakika-Kibwika P; Gasasira AF; Havlir D; Rosenthal PJ; Dorsey G; Achan J Future Virol; 2012; 7(7):699-708. PubMed ID: 23293660 [TBL] [Abstract][Full Text] [Related]
42. Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Scarsi KK; Fehintola FA; Ma Q; Aweeka FT; Darin KM; Morse GD; Akinola IT; Adedeji WA; Lindegardh N; Tarning J; Ojengbede O; Adewole IF; Taiwo B; Murphy RL; Akinyinka OO; Parikh S J Antimicrob Chemother; 2014 May; 69(5):1370-6. PubMed ID: 24446424 [TBL] [Abstract][Full Text] [Related]
43. Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans. Idemyor V HIV Clin Trials; 2007; 8(4):246-53. PubMed ID: 17720665 [TBL] [Abstract][Full Text] [Related]
44. Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients. Abgrall S; Le Bel J; Lele N; Laouénan C; Eychenne N; Mentré F; Peytavin G; Bouchaud O; HIV Clin Trials; 2013; 14(6):313-8. PubMed ID: 24334184 [TBL] [Abstract][Full Text] [Related]
50. Lopinavir/ritonavir enhanced the antimalarial activity of amodiaquine and artesunate in a mouse model of Plasmodium berghei. Abiodun OO; Gbimadee N; Gbotosho GO J Chemother; 2016 Dec; 28(6):482-486. PubMed ID: 26900802 [TBL] [Abstract][Full Text] [Related]
51. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA; Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068 [TBL] [Abstract][Full Text] [Related]
53. Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA). Manirakiza A; Sepou A; Serdouma E; Gondje S; Bata GG; Moussa S; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Vray M Trials; 2013 Aug; 14():255. PubMed ID: 23945130 [TBL] [Abstract][Full Text] [Related]
54. The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatment. Maganda BA; Ngaimisi E; Kamuhabwa AA; Aklillu E; Minzi OM Malar J; 2015 Apr; 14():179. PubMed ID: 25906774 [TBL] [Abstract][Full Text] [Related]